Spravato has been approved since 2019 for TRD, with its label extended the following year as a rescue therapy for adults with major depressive disorder (MDD) who were at risk of self-harm or suicide.

NHS patients with treatment-resistant depression in Scotland will be able to access Johnson & Johnson’s Spravato, a drug that has been turned down twice by NICE for patients in England.

So, if you don't identify as male or female, then what? Well, Facebook offers 56 options. You can use up to 10 of them on your profile. Fifty-six sounds like a lot, but actually a lot of them are ...

Samsung’s Galaxy S series phones are known for pushing the boundaries of what a smartphone can do, but the Galaxy A series is where my money’s at. The South Korean phone maker’s mid-range devices ...